Clinical Trial Update: A Study of XMT-1660 in Participants With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of XMT-1660 in participants with solid tumors is currently recruiting. The trial lists indications including triple-negative breast cancer, breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Breast Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• XMT-1660

Snippet

Sponsor: Mersana Therapeutics | Conditions: Triple Negative Breast Cancer, Breast Cancer | Phase 1 | Status: RECRUITING